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Summary. Enhanced apoptosis and elevated levels of reactive oxygen species
(ROS) play a major role in aging. In addition, several neurodegenerative
diseases are associated with increased oxidative stress and apoptosis in
neuronal tissue. Antioxidative treatment has neuro-protective effects. The
aim of the present study was to evaluate changes of susceptibility to apoptotic
cell death by oxidative stress in aging and its inhibition by the antioxidant
Ginkgo biloba extract EGb761. We investigated basal and ROS-induced lev-
els of apoptotic lymphocytes derived from the spleen in young (3 months) and
old (24 months) mice. ROS were induced by 2-deoxy-D-ribose (dRib) that
depletes the intracellular pool of reduced glutathione. Lymphocytes from
aged mice accumulate apoptotic cells to a signiﬁcantly higher extent under
basal conditions compared to cells from young mice. Treatment with dRib
enhanced this difference, implicating a higher sensitivity to ROS in aging.
Apoptosis can be reduced in vitro by treatment with EGb761. In addition,
mice were treated daily with 100mg/kg EGb761 per os over a period of two
weeks. ROS-induced apoptosis was signiﬁcantly reduced in the EGb761
group. Interestingly, this effect seemed to be more pronounced in old mice.
Keywords: Reactive oxygen species, aging, lymphocyte, programmed cell
death, 2-deoxy-D-ribose.
Introduction
Under normal physiological conditions, oxygen consumption by cells with
aerobic metabolism generates always potentially deleterious reactive oxygen
species (ROS), which are usually detoxiﬁed by several enzymes and physio-
logical antioxidants. A mismatch between production and detoxiﬁcation of
ROS leads to a state called oxidative stress and consequently to cellular
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damage. Oxidative stress seems to increase with age and is a major causal
factor of cellular damage and enhanced apoptosis in many aging tissues in-
cluding brain and the immune system (Buttke and Sandstrom, 1994; Leutner
et al., 2001).
Apoptosis is of particular interest not only in aging but also in many
degenerative diseases where it plays an important role in the pathological
processes. In the immune system, apoptosis of white blood cells could be one
reason for the immunosenescence related to cancer, infections and auto-
immune disorders (Bender et al., 1986).
Recently, our group (Schindowski et al., 2000) showed that peripheral
blood mononuclear cells (PBMC) of aged humans display a signiﬁcantly
higher content of basal apoptotic nuclei. In addition, oxidative stress-induced
apoptosis was signiﬁcantly higher in aged compared to young individuals. The
reducing sugar 2-deoxy-D-ribose (dRib) induces oxidative stress in several
kinds of cells (Barbieri et al., 1994; Ceruti et al., 1997) by depletion of intra-
cellular glutathione (GSH), leading to apoptosis (Eckert et al., 1998a;
Schindowski et al., 2000). Therefore, dRib provides a powerful tool to gener-
ate oxidative stress intracellularly and to induce apoptosis in vitro. In addi-
tion, we found that apoptosis of peripheral cells was increased in Alzheimer’s
disease (Schindowski et al., 1999). Most recently, we demonstrated that lym-
phocytes from presenilin-1 transgenic mice show a similar hypersensitivity to
cell death as do peripheral cells from AD patients (Eckert et al., 2001b).
These data further emphasize the excellent suitability of murine lymphocytes
to study mechanisms of cell death and to monitor the protective efﬁcacy of
potential therapeutic drugs in preclinical studies. In order to demonstrate that
enhanced apoptosis in aged humans is related to the aging process and not due
to presymptomatic Alzheimer’s disease, we investigated the basal and oxida-
tive stress-induced apoptosis in lymphocytes from young and aged mice to
exclude changes associated with AD. Moreover, the effects of the Ginkgo
biloba extract EGb761 on murine lymphocyte apoptosis were studied in vitro
and ex vivo in young and aged mice. The rationale for the pharmacological
intervention study is as follows: EGb761 is a potent antioxidant and has
already been shown to inhibit apoptosis in tissue culture experiments (Ni et
al., 1996; Ahlemeyer et al., 1999; Bastianetto et al., 2000a) and oxidative stress
in general (Kose et al., 1997; Pietri et al., 1997). Its effectiveness in
Alzheimer’s disease has been demonstrated by recent trials (Kanowski et al.,
1996; Le Bars et al., 1997; Maurer et al., 1997; Oken et al., 1998).
Methods
Animals
Young (3 months) and old (24 months) female NMRI mice used in this study were from
Harlan Winkelmann (Borchen, Germany). The latter were obtained at an age of 12
months and maintained at the Biocenter’s animal care facility until use. All animals were
housed in plastic cages with water and food ad libitum and were maintained on a 12-hour
light/dark cycle. Mice with skin lesions, spleenomegaly and macroscopically visible
tumors were excluded. For the ex vivo study, mice were treated daily with 100mg/kg
EGb761 per os in 0.2% agarose or with vehicle alone for 14 days. All experiments were
performed in accordance with the German animal right regulations.EGb761 in oxidative stress induced apoptosis 971
Reagents
2-deoxy-D-ribose (dRib) and propidium iodide (PI) were purchased from Sigma
(Taufkirchen, Germany). Anti-murine CD3-FITC-coupled monoclonal antibody was
from PharMingen (Heidelberg, Germany) and 7-AAD from Molecular Probes (Leiden,
The Netherlands). Anti-murine Pan-B beads were obtained from Dynal (Sweden).
RPMI-1640, fetal calf serum (FCS), penicillin, streptomycin, phosphate buffered saline
(PBS) and ethidium bromide stock solution were purchased from GibcoBRL
LifeTechnologies (Karlsruhe, Germany). Proteinase K and RNase A were from Roche/
Boehringer Mannheim (Mannheim, Germany). All other mentioned chemicals were
obtained from Merck (Darmstadt, Germany). Ginkgo biloba extract EGb761 was a kind
gift of Schwabe GmbH (Karlsruhe, Germany).
Cell preparation
Mice were killed by cervical dislocation. T cells were isolated from the spleen with
magnetic beads according to the manufacturer’s instructions. In brief, spleen cell suspen-
sions were prepared by mechanical dissociation of individual spleens in PBS supple-
mented with 10% FCS, penicillin (100U/ml) and streptomycin (100µg/ml). Red blood
cells were lysed in hypotonic buffer (155mM NH4Cl and 10mM KHCO3) for 2 minutes.
For B cell depletion, cells were washed twice, mixed with magnetic beads speciﬁc for B
cells and incubated with shaking for 20 minutes at 4°C. T cell content of spleen cells was
determined by CD3-staining to be over 80%. For short-term culture, lymphocytes were
seeded at 5  105 cells/ml in complete medium (RPMI-1640 supplemented with 10% FCS,
penicillin 100U/ml and streptomycin 100µg/ml) at 37°C and 5% CO2 in humidiﬁed
atmosphere. Cells were cultured in the absence and presence of 10mM dRib for 24 hours.
When indicated, spleen cells were preincubated with EGb761 for 1 hour before the
addition of dRib.
Detection of apoptosis with ﬂow cytometry
Cells were harvested at the indicated times by centrifugation (200  g, 5 minutes), and
resuspended in 50µg/ml propidium iodide in Na-citrate and 0.1% Triton X-100 for at least
10 minutes at 4°C in the dark (Nicoletti et al., 1991). DNA fragmentation was analyzed
by  ﬂow cytometry with FACSCalibur equipment using Cell Quest Software (Becton
Dickinson, Heidelberg, Germany) as previously described (Schindowski et al., 2000).
Sub-G0 DNA content is deﬁned as percentage of apoptotic cells.
For all conditions investigated, necrosis was excluded in preceding experiments
by staining with 7-Aminoactinomycin (7-AAD) according to the manufacturer’s
instruction.
DNA ladder
Cells were harvested by centrifugation (200  g, 5 minutes) and washed with PBS. Cell
pellets were incubated in 50mM TRIS (pH 7.5) containing 100mM NaCl, 1mM EDTA,
1% SDS and 20µg/ml proteinase K at 55°C overnight. After digestion with RNase A,
nucleic acids were extracted with phenol/chloroform and precipitated with 70% ethanol
according standard procedures. Genomic DNA was electrophoresed in a 1% agarose gel
and stained with ethidium bromide.
Statistics
Statistical signiﬁcance was determined by Student’s t-test with Graph Pad Software Prism
3.0. Data presented are means  S.E.M. Results were considered to be statistically
signiﬁcant when p  0.05.972 K. Schindowski et al.
Results
Basal levels of apoptotic nuclei
T cells were isolated from the spleens of young (3 months) and old (24
months) mice. To reduce activation or cell death of T cells during the isolation
procedure, B lymphocytes were removed by magnetic beads in order to leave
the T cells untouched. Basal DNA fragmentation assessed immediately after
isolation of the cells was analyzed by propidium iodide (PI) staining. Fluores-
cence intensity was plotted against number of counts. Signiﬁcantly increased
basal apoptotic levels could be determined in freshly isolated spleen cells
from old mice (2.18  0.23% apoptotic cells; n  13) compared to young mice
(1.77  0.26%; n  9; *p  0.05; Fig. 1A).
Oxidative stress enhances the age-related differences in apoptotic cell death
2-deoxy-D-Ribose (dRib) depletes the intracellular pool of reduced glu-
tathione thereby promoting states of enhanced oxidative stress inside the cell
(Ceruti et al., 1997; Barbieri et al., 1994). In earlier studies we showed that
oxidative stress induced by dRib signiﬁcantly ampliﬁes apoptotic cell death in
human aging and in Alzheimer’s disease (Schindowski et al., 2000). Here we
demonstrate that dRib is able to induce apoptosis as well in murine lympho-
cytes (Fig. 1B). To further conﬁrm the apoptotic nature of cell death, DNA
laddering of nuclear fragmentation was assessed in murine T cells from indi-
vidual mice. Figure 2 shows a representative experiment.
T cells of the spleen from young and old mice were incubated for 24 hours
in the presence of 10mM dRib. In vitro apoptosis of cells incubated over the
same period with medium alone was subtracted. Induction of oxidative stress
revealed age-related changes in programmed cell death. A signiﬁcant increase
towards higher apoptotic levels was found in spleen cells of aged animals (old:
7.90  1.55%; young: 2.21  0.45%; **p  0.01; n  9–13 in each group;
Fig. 1B).
In vitro effects of EGb761 on ROS-induced apoptosis in spleen cells
from young and old mice
To determine the protective potential of Ginkgo biloba extract on ROS-
induced apoptosis in vitro, freshly isolated spleen cells from young and old
mice were co-incubated with various doses of EGb761 and 10mM dRib for 24
hours. The level of ROS-induced apoptosis (dRib alone) occurring after 24
hours of any individual animal was taken as 100% (full apoptotic effect). The
percentage of basal apoptosis from freshly isolated lymphocytes was set as 0%
(Fig. 3). Ginkgo biloba extract decreased dRib-induced apoptosis at concen-
trations above 10µg/ml. Interestingly, EGb761 provides greater protective
properties in cells from aged animals. 250µg/ml and 500µg/ml revealed a
signiﬁcant reduction of apoptosis in aged mice compared to young mice. Since
absolute levels of dRib-induced apoptosis are higher in lymphocytes from old
animals (Fig. 1B), these ﬁndings demonstrate that cells from old mice
speciﬁcally beneﬁt from EGb761 treatment. In lymphocytes from young miceEGb761 in oxidative stress induced apoptosis 973
the reduction was less pronounced than in elderly animals. Two-way ANOVA
revealed signiﬁcant differences between mice groups and treatment with
EGb761 (10–500µg/ml; p  0.05).
Ex vivo effects of EGb761 on ROS-induced apoptosis in young and old mice
In order to explore the effect of Ginkgo biloba extract on chronically treated
cells and to determine its ex vivo anti-apoptotic function, we treated young
and old mice with EGb761 in 0.2% agarose or with agarose alone as placebo
over a period of 2 weeks. The dose used (100mg/kg) has previously been
Fig. 1. Basal (A) and dRib-induced (B) apoptosis in T cells of young and old mice.
Percent sub-G0 DNA content (termed as apoptotic cells) in freshly isolated lymphocytes
derived from young (3 months of age, white bars) and old (24 months of age, gray bars)
animals are shown. A Apoptotic cell death was determined immediately after isolation,
B cells were incubated for 24 hours at 37°C in the presence of dRib (10mM). Data are
means  S.E.M.; n  9–13 per group, *p  0.05; **p  0.01. Basal apoptosis describes the
total amount of apoptotic cells of freshly isolated spleen cells. ROS-induced apoptosis is
deﬁned as the percentage of apoptosis in dRib-treated cultures subtracted by the spon-
taneous apoptosis, which occurs when culturing primary cells over a while under in vitro
conditions. The spontaneous apoptosis was not altered between the two age groups974 K. Schindowski et al.
Fig. 2. Apoptotic cell death pattern in murine lymphocytes under basal conditions. Im-
mediately after isolation, levels of apoptotic cells are too low, to give a detectable DNA
ladder formation. After 24 hours incubation with dRib, a substantial apoptotic endo-
nuclease activity occurs, which is evident by cleavage of chromosomal DNA between the
nucleosomes producing oligomers of 180 basepairs (typical “DNA ladder”)
Fig. 3. Prevention of ROS-induced apoptosis by increasing doses of EGb761 in vitro.
Percentage of apoptotic lymphocytes after 24 hours incubation without EGb761 treat-
ment were deﬁned as 100%. Basal apoptosis of freshly isolated spleen cells was deﬁned as
0%. The anti-apoptotic effects of EGb761 at a concentration of 250µg/ml and higher
differ signiﬁcantly between the two groups (n  3 per group, **p  0.01; *p  0.05)EGb761 in oxidative stress induced apoptosis 975
shown to improve learning deﬁcits in aged mice (Stoll et al., 1996). After 14
days of treatment, mice were killed by cervical dislocation and spleens were
prepared as described above. No effect of EGb761 on basal apoptosis could
be seen in either group (young: placebo; 1.77  0.26%; EGb761, 1.76 
0.28%, n  9 per group; old: placebo, 2.18  0.23%; EGb761, 2.19  0.31%,
n  13 per group), indicating no direct in vivo effect of EGb761 on physiologi-
cal apoptosis. In contrast, ex vivo ROS-induced apoptosis triggered by treat-
ment with dRib was signiﬁcantly reduced in the placebo group of young
animals (placebo: 100.0  3.10%; EGb761: 79.80  3.58%; n  9 in each
group; ***p  0.001; Fig. 4A). Interestingly, as already shown by our in vitro
experiments, lymphocytes from old animals revealed a signiﬁcantly (placebo
old: 55.55  10.65% vs. placebo young: 79.80  3.58%; *p  0.05) greater
protection by the plant extract than did cells from younger mice (old, placebo:
100.0  23.51%; EGb761 group 55.55  10.65%; n  13 per group; †p  0.05;
Fig. 4B).
Discussion
ROS occur as physiological intermediates in aerobic metabolism and are
usually eliminated inside cells by antioxidant pathways that require reduced
Fig. 4. Effect of oral EGb761-treatment on ROS-induced apoptosis in spleenic T cells
from young and old mice. Young (A) and old (B) female NMRI mice were treated with
100mg/kg EGb761 or vehicle orally for 2 weeks. T cells were isolated from the spleens
and incubated with 10mM dRib for 24 hours. Mean levels of dRib-induced apoptosis of
the placebo group were set 100% (100% full apoptotic effect). Basal apoptosis of freshly
isolated spleen cells was deﬁned as 0%. A In spleen cells from young animals, ROS-
induced apoptosis was diminished by EGb761 by about 20% when compared with
placebo treated mice (n  9 per group, ***p  0.001). B In cells derived from old mice
this effect was even more ampliﬁed. Apoptosis was reduced by about 45% in the EGb761-
treated group, though levels ﬂuctuated more in aged animals (n  13 per group,
*p  0.05). However, cells from aged mice revealed a signiﬁcant greater beneﬁt from
EGb761-treatment than lymphocytes of young animals did [placebo old (B) vs. placebo
young (A): †p  0.05]976 K. Schindowski et al.
glutathione (GSH) for regeneration. dRib provokes oxidative stress in cells.
There are growing evidences that the underlying mechanism is diminishing
the intracellular levels of GSH (Kletsas et al., 1998) and it seems to be
therefore involved in the formation of free radicals (Ceruti et al., 1997;
Schindowski et al., 2000). Depletion of GSH makes the cell defenseless
against elevated levels of ROS, which can trigger the cell to undergo apoptosis
by DNA damage or directly act as second messengers in the apoptotic path-
way. Buttke and Sandstrom (1994) found that apoptosis in lymphocytes is
often mediated by ROS, considering that already low concentrations of per-
oxides can initiate apoptosis. Therefore, dRib represents a useful tool to
generate intracellular oxidative stress in lymphocytes (Barbieri et al., 1994;
Eckert et al., 1998, 1998a). In recent studies, we clearly demonstrated that
T-cells can cope less effectively with oxidative stress during aging in man and
that this effect is ampliﬁed in Alzheimer’s disease (Eckert et al., 1998b;
Schindowski et al., 1999). In the present study, we conﬁrmed that lymphocytes
derived from old mice are also more vulnerable to dRib-induced apoptosis
than lymphocytes from young mice. Proposing that dRib exhausts the glu-
tathione pool, cells that generate more ROS should be more prone to
apoptosis. Since apoptosis is signiﬁcantly elevated in dRib treated cells from
elderly mice, one can conclude that lymphocytes derived from old animals as
compared with young, either generate more ROS during metabolism or are
more sensitive to ROS. However, we can not exclude higher sensitivity of old
animals to dRib.
Several in vitro studies using primary neurons in tissue culture have al-
ready shown that EGb761 can protect from oxidative stress-induced cell death
(Bastianetto et al., 2000b; Chen et al., 1999; Ahlemeyer et al., 1999; Ni et al.,
1996). Our results conﬁrm and extend these ﬁndings by demonstrating that
the protective effect of EGb761 is (1) also seen in fully differentiated lympho-
cytes in vitro and (2) can also be observed after ex vivo treatment where it
seems to take place at lower concentrations. Moreover, our experiments
reveal that EGb761 treatment has a higher protective effect in cells derived
from elderly animals and that the degree of protection is similar in vitro and
in vivo. In an earlier study, we demonstrated that dRib enhances signiﬁcantly
the levels of ROS in peripheral lymphocytes isolated from aged humans
(Schindowski et al., 2000). Therefore, one might speculate that the percentage
of prevention by EGb761 is greater, as more radicals generated by dRib can
be eliminated. Even more important, apoptotic mechanisms needed for the
physiological elimination of cells (basal apoptosis) were not affected by the
EGb761 treatment. This fact may be relevant to the physiological role of
programmed cell death in carcinogenesis, development, and homeostasis of
the immune system. However, “pathological apoptosis” e.g. apoptosis in-
duced by an additional stimulus, which seems to mimic enhanced oxidative
stress in pathological conditions like Alzheimer disease, can be signiﬁcantly
prevented by Ginkgo treatment. Thus, the ﬁndings not only demonstrate that
enhanced vulnerability to oxidative stress-induced apoptosis is a common
feature of aged lymphocytes, but also that EGb761 might speciﬁcally interfereEGb761 in oxidative stress induced apoptosis 977
with this pathological mechanism, leaving physiological aspects of pro-
grammed cell death rather unaffected.
Based on our ﬁndings, lymphocytes seem to represent a suitable model
system for monitoring drug effects on cell death mechanisms in further pre-
clinical and clinical studies using EGb761 or other antioxidant drugs.
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